Ultragenyx (RARE) stock news · rev $673.0M
Ultragenyx (RARE) is a biotechnology company listed on US.
This RARE news page leads with what Ultragenyx filed — not a scraped headline mill.
No cached 8-K sentence for RARE yet. We will not pad this page with generic market recap.
Latest reported RARE revenue for 2025-12-31 was $673.0M. Net income was -$575.0M. Revenue was up 20.1% from 2024-12-31 to 2025-12-31. RARE currently screens at market cap $2.79B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RARE stock page; for the tape open the quote page.
RARE stock news FAQ
What are RARE's latest revenue and net income?
Latest cached Ultragenyx (RARE) revenue for Dec 31, 2025 was $673.0M. Net income was -$575.0M. Statements: https://lician.com/financials/rare
How did RARE revenue change from the prior cached period?
Cached Ultragenyx (RARE) revenue was up 20.1% from $560.2M (Dec 31, 2024) to $673.0M (Dec 31, 2025). Statements: https://lician.com/financials/rare
What is RARE's market cap?
Ultragenyx (RARE) market cap is $2.79B on the latest cached fundamentals snapshot.
What kind of company is RARE?
Ultragenyx (RARE) is a biotechnology company listed on US.
Where is RARE stock news listed?
Cached stock news for Ultragenyx (RARE) is listed at https://lician.com/news/rare. Filings: https://lician.com/sec/rare
Not investment advice.